At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BK4007 Pharmacy
Trading 02-04 12:45:32 EST
915.47
+31.54
+3.57%
High920.25Low883.71Vol212.95M
Open883.92D1 Closing883.93Amplitude4.13%
Mkt Cap0.00Tradable Cap0.00Total Shares0.00
T/O12.59BT/O Rate--Tradable Shares0.00
P/B5.468424ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Shanghai Pharmaceuticals Holding to Divest 30% Stake in Sino-American Shanghai Squibb Through Public Listing
Stock News  ·  02-04 17:42
Shanghai Pharmaceuticals Holding to Divest 30% Stake in Sino-American Shanghai Squibb Through Public Listing
Novo Nordisk Guidance Implies Deep Cuts to Consensus -- Market Talk
Dow Jones  ·  02-04 17:25
Novo Nordisk Guidance Implies Deep Cuts to Consensus -- Market Talk
Analysts Offer Insights on Healthcare Companies: Merck KGaA (GB:0O14) and Moderna (MRNA)
TIPRANKS  ·  02-04 17:01
Analysts Offer Insights on Healthcare Companies: Merck KGaA (GB:0O14) and Moderna (MRNA)
GlaxoSmithKline Exceeds Q4 Profit Expectations Driven by HIV Medications
Stock News  ·  02-04 16:48
GlaxoSmithKline Exceeds Q4 Profit Expectations Driven by HIV Medications
GSK's Guidance Implies FX Headwind -- Market Talk
Dow Jones  ·  02-04 16:25
GSK's Guidance Implies FX Headwind -- Market Talk
Generic Drug Competition Intensifies, Novartis Forecasts 2026 Profit Decline
Stock News  ·  02-04 15:50
Generic Drug Competition Intensifies, Novartis Forecasts 2026 Profit Decline
Novo Nordisk Earnings: NVO Stock Drops as Weak 2026 Forecast Dampens Q4 Beat
TIPRANKS  ·  02-04 15:36
Novo Nordisk Earnings: NVO Stock Drops as Weak 2026 Forecast Dampens Q4 Beat
GlaxoSmithKline Projects Slower Revenue Growth for 2026
Deep News  ·  02-04 15:30
GlaxoSmithKline Projects Slower Revenue Growth for 2026
BRIEF-Oxford BioMedica Signs Multi-Year Supply Agreement With Bristol Myers Squibb
Reuters  ·  02-04 15:12
BRIEF-Oxford BioMedica Signs Multi-Year Supply Agreement With Bristol Myers Squibb
Oxford Biomedica Plc - Signs Multi-Year Supply Agreement With Bristol Myers Squibb
THOMSON REUTERS  ·  02-04 15:00
Oxford Biomedica Plc - Signs Multi-Year Supply Agreement With Bristol Myers Squibb
Oxford Biomedica Plc: Multi-Year Agreement With Five-Year Initial Term and Option to Extend
THOMSON REUTERS  ·  02-04 15:00
Oxford Biomedica Plc: Multi-Year Agreement With Five-Year Initial Term and Option to Extend
Oxford Biomedica Plc: Under New Agreement, Oxb Is Expected to Commence Commercial Manufacturing in 2026
THOMSON REUTERS  ·  02-04 15:00
Oxford Biomedica Plc: Under New Agreement, Oxb Is Expected to Commence Commercial Manufacturing in 2026
Novo Nordisk Shares to Open Lower as Guidance Disappoints -- Market Talk
Dow Jones  ·  02-04 14:58
Novo Nordisk Shares to Open Lower as Guidance Disappoints -- Market Talk
Novo Nordisk's shock 2026 guidance points to obesity battle heating up
Reuters  ·  02-04 14:40
Novo Nordisk's shock 2026 guidance points to obesity battle heating up
ELAN FY Net Y2.77B Vs Net Y2.35B
Dow Jones  ·  02-04 14:30
ELAN FY Net Y2.77B Vs Net Y2.35B
Novo Nordisk Q4 EPS $0.94 Beats $0.89 Estimate, Sales $12.335B Beat $12.080B Estimate
Benzinga  ·  02-04 14:26
Novo Nordisk Q4 EPS $0.94 Beats $0.89 Estimate, Sales $12.335B Beat $12.080B Estimate
Novartis Q4 Adj. EPS $1.26 Misses $1.99 Estimate, Sales $13.336B Miss $13.781B Estimate
Benzinga  ·  02-04 14:18
Novartis Q4 Adj. EPS $1.26 Misses $1.99 Estimate, Sales $13.336B Miss $13.781B Estimate
Teva’s Sustainability Disclosures Face Rising Legal and Investor Risk Amid Global Compliance Demands
TIPRANKS  ·  02-04 14:00
Teva’s Sustainability Disclosures Face Rising Legal and Investor Risk Amid Global Compliance Demands
Hope Life International Eyes 51% Stake in Guangdong CBD; Shares Fall 5%
MT Newswires Live  ·  02-04 11:46
Hope Life International Eyes 51% Stake in Guangdong CBD; Shares Fall 5%
Balanced Near-Term Pipeline Upside Versus Structural Profit Headwinds Keeps Pfizer at Hold
TIPRANKS  ·  02-04 10:56
Balanced Near-Term Pipeline Upside Versus Structural Profit Headwinds Keeps Pfizer at Hold

Introduction

Company Name.
BK4007
Affiliated Markets:
Listing Date:
--
Main Business:
Issue price:
--